People living with early Alzheimer’s disease can now begin treatment with Leqembi without setting foot in an infusion center.
Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...
When Sanofi won FDA approval in July 2026 for the first anticancer treatment administered with an on-body injector (OBI), the Enable Injections enFuse platform made it possible. The enFuse OBI secured ...
A new under‑the‑skin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...
According to Carney, who was present for his birth, Tornado was the biggest puppy of the litter and has lived up to his name ...